Microdeletion of 22q11.1 is associated with two cases of familial nonsyndromic basal cell carcinoma

Cancer Genetics and Cytogenetics

Volumn 202, Issue 2, 2010, Pages 133-135

  Naderi, Ali ^a,b  

^a BEDFORD HOSPITAL NHS TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PROTEIN PATCHED 1;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CASE REPORT; CHROMOSOME 22Q; CHROMOSOME DELETION; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE DURATION; FAMILIAL CANCER; FEMALE; GENE MAPPING; HUMAN; MALE; MULTIPLE CANCER; PRIORITY JOURNAL; RADIODIAGNOSIS; CHROMOSOME 22; FAMILY; GENETICS; PEDIGREE; SKIN TUMOR;

ADULT; AGED; CARCINOMA, BASAL CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; FAMILY; FEMALE; HUMANS; MALE; PEDIGREE; SKIN NEOPLASMS;

EID: 77957046327     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.07.123     Document Type: Article

References (7)

1. Gorlin R.J. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 2004, 6:530-539.
2. Hahn H., Wicking C., Zaphiropoulous P.G., Gailani M.R., Shanley S., Chidambaram A., et al. Mutation of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996, 85:841-851.
3. Happle R. Nonsyndromic type of hereditary multiple basal cell carcinoma. Am J Med Genet 2000, 95:161-163.
4. Coquart N., Meyer N., Lemasson G., Conan V., Hu W., Misery L. A new non-syndromic type of familial carcinomas?. J Eur Acad Dermatol Venereol 2009, 23:223-224.
5. Guarneri B., Borgia F., Cannavò S.P., Vaccaro M., Happle R. Multiple familial basal cell carcinomas including a case of segmental manifestation. Dermatology 2000, 200:299-302.
6. Zaphiropoulos P.G., Undén A.B., Rahnama F., Hollingsworth R.E., Toftgård R. PTCH2, a novel human patched gene, undergoing alternative splicing and up-regulated in basal cell carcinomas. Cancer Res 1999, 59:787-792.
7. O'Neal J., Gao F., Hassan A., Monahan R., Barrios S., Kilimann M.W., et al. Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma. Exp Hematol 2009, 37:234-244.